Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia
NCT07414693 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2026-02-17
Summary
Severe pneumonia is a common and serious illness in young children and often requires hospital admission. This clinical trial aims to find out whether adding vitamin C to standard treatment can reduce the length of hospital stay in children under five years of age admitted with severe pneumonia.
The main question this study seeks to answer is:
Does giving vitamin C along with routine treatment help children with severe pneumonia recover faster and go home earlier compared to standard treatment alone?
In this study, 90 children aged 2 to 59 months who are admitted to the Children's Hospital Multan with severe pneumonia will take part. Severe pneumonia is defined by fast breathing, fever, cough, and one or more danger signs such as difficulty feeding, repeated vomiting, seizures, bluish discoloration of lips, or noisy breathing. Children with chronic lung disease or weakened immunity will not be included.
After parental consent, children will be randomly divided into two groups. One group will receive standard treatment only, which includes oxygen therapy and intravenous antibiotics according to hospital protocol. The second group will receive the same standard treatment plus a daily dose of vitamin C. Neither group will receive any experimental or unapproved therapy.
Researchers will closely monitor each child's recovery, including improvement in breathing rate, temperature, oxygen levels, and overall clinical condition. The child will be discharged when the treating physician determines that recovery criteria are met. The number of days spent in the hospital from the start of treatment until discharge will be recorded.
By comparing the average hospital stay between the two groups, this study aims to determine whether vitamin C is a useful and safe add-on treatment for severe pneumonia in young children. The findings may help improve care and reduce hospital stay for children with severe pneumonia in the future.
Conditions
- Pneumonia Childhood
- Vitamin C
- Hospital Stay Time
Interventions
- DRUG
-
Antibiotics administration
Antibiotics Plus supportive care including oxygen inhalation, intravenous rehydration, and antipyretics
- DRUG
-
Vitamin C
Standard care (oxygen inhalation, intravenous rehydration, and antipyretics) plus Vitamin C: 200-mg (2 cc = 4 dropper, should be mixed in milk or water) once a day
Sponsors & Collaborators
-
Children's Hospital and Institute of Child Health, Multan
lead OTHER_GOV
Principal Investigators
-
Ayesha F Assitant Professor, FCPS · Children Hospital and Institute of Child Health, Multan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-28
- Primary Completion
- 2026-02-27
- Completion
- 2026-02-27
Countries
- Pakistan
Study Locations
More Related Trials
-
VCSIP Follow-up Study
NCT03203603 ·Status: COMPLETED
-
High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM
NCT00388921 ·Status: COMPLETED ·Phase: NA
-
Vitamin A Supplementation at Birth and Atopy in Childhood
NCT01779180 ·Status: UNKNOWN
-
Reducing Pain and Anxiety Through Dietary Fiber Supplementation in Children With Abdominal Pain
NCT04619095 ·Status: WITHDRAWN ·Phase: NA
-
L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)
NCT06426147 ·Status: RECRUITING ·Phase: NA
-
Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets
NCT04199624 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker
NCT06489951 ·Status: COMPLETED ·Phase: NA
-
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function
NCT01723696 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vitamin A for BPD Prevention
NCT04563429 ·Status: UNKNOWN ·Phase: NA
-
Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants
NCT03876704 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Parental Peri-conceptional Vitamin B12 Supplementation on Infant Neurocognitive Development in Offspring
NCT03088189 ·Status: TERMINATED
-
Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development
NCT00479479 ·Status: COMPLETED ·Phase: NA
-
Vitamin A Supplementation in Preterm Infants
NCT00063596 ·Status: UNKNOWN ·Phase: NA
-
First-day High Dose Vitamin C, E in Severe Birth Asphyxia
NCT01743742 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerance of an Oral Nutritional Supplement(ONS)
NCT01782456 ·Status: COMPLETED ·Phase: NA
-
The Effect of Vitamin C on Growth Hormone Secretion
NCT01537094 ·Status: WITHDRAWN ·Phase: PHASE2
-
Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis
NCT01697059 ·Status: COMPLETED ·Phase: NA
-
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
NCT00728104 ·Status: WITHDRAWN
-
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
NCT01617044 ·Status: COMPLETED ·Phase: PHASE2
-
Fruit and Vegetable Juice Concentrate Effects on RBP4 and Antioxidant Capacity in Lean and Overweight 6-10 Year Old Boys
NCT00842543 ·Status: COMPLETED ·Phase: NA
-
Palatability of Oral Rehydration Solutions
NCT00689312 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis
NCT00707785 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Association Between Vitamin C Deficiency and Diarrhea in Children
NCT05328037 ·Status: COMPLETED
-
Mitochondrial Complex I Dysfunction in PWS
NCT03831425 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of Folic Acid Supplementation in Acute Watery Diarrhea Among Children Under 5 Years of Age
NCT04782037 ·Status: UNKNOWN ·Phase: PHASE4